On April 20th, it was learned from the 2025 China Medical Development Conference that the Chinese Academy of Medical Sciences released the "Important Medical Advances in China 2024", which covers 13 major achievements in stroke treatment, gene therapy, disease prediction, and more. Among them, the gene therapy program that can accurately diagnose and detect patients with hereditary deafness 18 years before the onset of symptoms of Alzheimer's disease is particularly noteworthy, and these advances will significantly improve the level of disease prevention and treatment. The results of this release were selected from more than 310000 medical studies, including the development of a new ultra time window intravenous thrombolysis scheme in acute ischemic stroke, which significantly reduced the disability rate of patients, confirmed the long-term effectiveness of adult recombinant hepatitis E vaccine, and revealed a new nano enzyme mechanism that effectively improved wound healing in diabetes. Research shows that elderly people with moderate obesity but lower waist circumference have a lower risk of mortality; Another team has discovered the key molecular mechanism of inflammatory blood-brain barrier disruption, providing new targets for related treatments. The selection process is undertaken by the Academic Advisory Committee of the Chinese Academy of Medical Sciences. After a rigorous process of big data multivariate quantitative evaluation and selection, as well as communication evaluation, the 13 most valuable medical advances were ultimately determined. Since its launch in 2020, the annual important medical progress has been released for six consecutive years, aiming to guide the direction of medical innovation, enhance social attention to medical science, and promote scientific research achievements to benefit public health. (New Society)